[Jaundice and rifampicin. Critical study].
D000937:Antigen-Antibody Reactions; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D004347:Drug Interactions; D005260:Female; D006801:Humans; D006932:Hyperbilirubinemia / Q000209:etiology; D007538:Isoniazid / Q000009:adverse effects; D008297:Male; D011379:Prognosis; D012293:Rifampin / Q000009:adverse effects* / Q000627:therapeutic use; D013223:Statistics as Topic; D000637:Transaminases / Q000032:analysis; D014376:Tuberculosis / Q000188:drug therapy
D000637:Transaminases; D007538:Isoniazid; D012293:Rifampin
Ictères et rifampicine. Etude critique